The Use of Curcumin to Mitigate the Inclusion of ALPHA-synuclein in Transgenic Caenorhabditis elegans
ISEF · 2020 Biomedical and Health Sciences
Overview
Aggregation of the protein alpha-synuclein causes symptoms of Parkinson’s Disease in human brains. Treatment of transgenic NL5901 C. elegans with the xenohormetic phytochemical curcumin was administered to decrease the aggregation of a-synuclein and maintain the proteostasis of the nematode. NGM agar plates with and without 20um curcumin were seeded with OP50 E. coli, and worms were then transferred onto the plates and allowed to grow to adulthood. Viewing of YFP-tagged alpha-synuclein occurred via Carl Zeiss Axiovert 40 CFL fluorescence microscope at 514 nm, and images were analyzed for fluorescence intensity via ImageJ software. Fluorescence intensity of treated worms was observed to be significantly (p<0.05) lower than untreated worms, suggesting that curcumin has the ability to decrease alpha synuclein aggregation in aging animals.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2024
Analyzing the Effects of Curcumin and Turmeric on the Accumulation of Tau and Amyloid Protein and Its Further Implications Into Alzheimer's Disease
ISEF · 2023
Analyzing the Effects of Turmeric & Curcumin on Tau Aggregation & Amyloid Beta Plaques on Caenorhabditis elegans and Its Further Implications Into Alzheimer's Disease
ISEF · 2022
Parkinson's Disease: Assessing the Effect of a Polyphenolic Compound on Alpha-Synuclein Aggregation in Lab Afflicted Drosophila melanogaster
ISEF · 2015
Mis-Disordered Tau Protein Interactions with Curcuma longa Utilizing a C. elegans Model
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair